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Abstract
At the physiological level, aging is neither rigid nor unchangeable. Instead, the molecular and mech-
anisms driving aging are sufficiently plastic that a variety of diverse interventions–dietary, pharma-
ceutical, and genetic–have been developed to radically manipulate aging. These interventions, shown
to increase the health and lifespan of laboratory animals, are now being explored for therapeutic
applications in humans.
This clinical potential makes it especially important to understand how, quantitatively, aging
is altered by lifespan-extending interventions. Do interventions delay the onset of aging? Slow it
down? Ameliorate only its symptoms? Perhaps some interventions will alter only a subset of aging
mechanisms, leading to complex and unintuitive systemic outcomes. Statistical and analytic models
provide a crucial framework in which to interpret the physiological responses to interventions in aging.
This review covers a range of quantitative models of lifespan data and places them in the context
of recent experimental work. The careful application of these models can help experimentalists move
beyond merely identifying statistically significant differences in lifespan, to instead use lifespan data
as a versatile means for probing the underlying physiological dynamics of aging.
• Death involves the final collapse of vital physiological networks, and the timing of this collapse
provides a systems-level measure of aging.
• Many of the best models for lifespan data common in the clinical literature are rarely applied
in basic research studies of aging.
• Multivariate regression models allow differences between experimental replicates to be explicitly
measured and accounted for when estimating the effect of interventions.
• Semi-parametric models allow interventions to be studied with fewer implicit assumptions re-
garding the empiric data.
• Frailty models extend parametric and semi-parametric approaches to more accurately account
for unmeasured heterogeneity.
• Competing risk models and mixture models provide a formal framework for studying multi-
causal aging processes.
• Common models, like the Gompertz parametric model, are accurate only when experimental
data exhibit particular geometric patterns. These patterns are often not present.
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Douglas Adams once said that “There is an art to flying, or rather a knack. The knack lies
in learning how to throw yourself at the ground and miss.” Immortality requires learning a similar
knack: you must first be born and then subsequently avoid dying forever. This is challenging in
part because there are many different causes of death to avoid–accidents, infections, cancer, heart
disease, neurodegenerative disorders–and because our bodies slowly change in ways that make most of
these causes of death increasingly probable (Fig. 1). As the risks of occurrence for different diseases
increase, their contributions add up to produce a doubling in all-cause mortality risk approximately
every eight years [1]. The specific physiological changes driving these increases in disease-specific
mortality risk remain uncertain, motivating intense research into the molecular, cellular, and systems
biology of aging.
The mathematics governing increases in the risk of death are non-trivial and can appear obscure
or arcane to experimental biologists who may lack formal training in probability theory and statistics.
Yet a general understanding of the models used to analyze lifespan data are nevertheless important
for molecular, cell, and systems biologists. In a clinical context, the mathematics and statistical
models of lifespan highlight the many challenges ahead for proponents of radical lifespan extension–
delaying or eliminating a small number of causes of death can yield only an incremental effect on
lifespan. For example, it is estimated that curing all cancers would produce less than four years of
extended lifespan[2]. The reason for this is intuitive–elderly patients, cured of a particular disease,
remain highly likely to succumb to any of multiple other diseases, and so live (on average) only a little
longer–but explanations of the statistics governing this are often impenetrable for non-specialists. A
basic understanding of quantitative models are also important in the basic research, as much of the
work in molecular and cell biology today remains focused on mechanisms whose involvement in aging
was at least initially justified by those mechanisms’ effect on lifespan. Experimental researchers need
to be critical judges of this evidence.
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Figure 1: Systems-level measurement of complex physiological processes. The risk of death from the seven
most frequent causes of non-accidental death is shown, corresponding to 70% of all deaths reported in the USA in 2015
[1]. Cause-specific risks (colored lines) sum up to produce the all-causes hazard function (black). Each cause exhibits
distinctive age-dependent effects, though substantial correlations exist among the causes.
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1. Describing aging using hazard and survival functions
Most analyses of lifespan data are grounded in study of two related mathematical functions–the
survival curve and the hazard function. The hazard function provides an intuitive measure of the
risk of death, defined as the probability that a typical individual who is currently alive will soon die.
This probability is much higher in older individuals compared to younger ones, usually interpreted
as evidence of some physiological weakness or susceptibility to death shared among old individuals
not present in the young. Over the last forty years, it has become very clear that this increase in
risk does not emerge from some universal natural law. The shape of hazard functions is a product
of evolutionary forces and varies enormously between species [3]. In fact, a mammal, the naked mole
rat, has recently been shown to exhibit a nearly constant hazard function [4]. Formally, the hazard
function is defined as a conditional probability, h(t) = limP (T ≤ t + ∆t|T > t) as ∆t → 0, and is
usually estimated and plotted as the rate h(t) = P (t < T ≤ t+ ∆t)/P (T > t) .
The survival curve is a different function that describes the fraction of a population remaining alive
over time. At the start of an observational period, this fraction is one and then drops each time an
individual dies. The survival function is formally defined as the cumulative probability of remaining
alive, S(t) = P (T > t). The cumulative probability of remaining alive obviously is related to the
risk of death, governed by the relation S(t) = exp
(− ∫ τ
0
h (τ) dτ
)
. Though the hazard function often
provides a clearer visualization of patterns in mortality, any model of lifespan data can be equivalently
stated in terms of the survival function.
2. Identifying changes in lifespan with non-parametric methods
The analysis of lifespan data usually involves the application of a non-parametric test used to
identify statistically significant changes in lifespan. Common methods include the log-rank, Wilcox,
and the modified Kolmogorov-Smirnov (KS) tests, all of which ask whether two populations lifespan
correspond to the same underlying survival and hazard function. These tests make relatively few
assumptions about the statistical properties of the underlying lifespan data, and so have remained in
continuous use for decades without substantial modification. However, this lack of assumptions leads
to a lack of interpretability–most non-parametric tests can show that lifespan has been altered but
not how it has been altered. Recently, non-parametric approaches have been developed to distinguish
changes in mean lifespan from changes in the variation in lifespan, as part of a pace-shape framework
[5].
3. Modeling the hazard function with parametric models
Parametric models go beyond non-parametric models by positing that lifespan data can be accu-
rately described by simple mathematic functions with a small number of free parameters. In data
where this assumption holds, parametric functions allow researchers to describe complex data sets
using a small number of parameters, providing straightforward geometric interpretations of how inter-
ventions effect lifespan. For example, the commonly used Gompertz model assumes that populations
exhibit hazard functions that increase exponentially over time (Fig. 2 a-d), following a straight line
on a log-linear plot. This model has been shown to provide an adequate approximation for some
human populations [6, 7] as well as some invertebrate populations [8, 9]. Yet, the shape of hazard
functions vary enormously between species [3] and despite its popularity, the Gompertz model is
frequently out-performed by several other two-parameter distributions. These include the Weibull
model[10], that assumes a polynomial increase in the risk of death over time (Fig. 2 e-f), as well
as the inverse-Gaussian model (Fig. 2 g-h) which notably has a compelling theoretic grounding in
the statistical physics of Brownian motion [11, 12]. Other parametric alternatives include Gompertz-
Makeham, log-logistic, and log-normal models. Parameter estimates can be obtained by a variety
of methods[13, 14], with maximum-likelihood estimation approaches[15] almost always producing the
most accurate results.
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Different explanations have been proposed to explain why physiological aging processes might yield
lifespan distributions conforming to simple parametric forms. The more quantitative of these theories
draw on a mix of reliability theory [16], complex networks theory [17], and statistical physics [18], and
this area remains a topic of active research. One interpretation shared among most parameterizations
involves a single timescale or rate parameter that uniquely governs the time-dependent increase of
the hazard functions including the Gompertz b parameter, the Weibull β parameter, and the Inverse
Gaussian λ parameter. These timescale parameters are used to quantify a population’s “rate of aging,
a measure of some average speed at which physiologically young individuals change into old individuals.
This rate of aging is then distinguished from other model parameters that describe distinct aspects
of aging distinct from essential rate, allowing interventions to be qualitatively categorized according
to their distinct effects on different parameters [19, 20, 9, 21], [22]. Most of the common parametric
models differ primarily in the interpretation of their non-timescale parameter and secondarily in the
accuracy of their approximation of empiric data. The major limitation to parametric methods is
that for most data sets, there does not exist a single unambiguously best parameterization for the
underlying empiric data. In cases where different parameterizations can equally-well approximate
empiric data, the different parametrizations provide multiple, discordant interpretations of the same
underlying data. The most common reasons for this are described later in the frailty section.
4. Modeling changes in lifespan with semi-parametric methods
Semi-parametric models improve on parametric approaches by eliminating the necessity of picking
one simple mathematic function to represent survival and hazard functions. Semi-parametric models
parameterize only the action of the intervention itself–hence the name ”semi-parametric”. They
provide a more flexible means for making relative statements comparing two populations. Theory
would predict that semi-parametric methods require larger population sizes compared to parametric
methods to achieve the same statistical power and significance. However these costs are often minor
[23], especially compared to the complications that arise when poor-fitting fully-parametric forms are
used.
The two most common families of semi-parametric models are Proportional Hazards (PH) models
and Accelerated Failure Time (AFT) models. Proportional hazards models assume interventions
alter the hazard function to produce a time-independent proportional change in the risk of death.
In practice, this means that PH models assume that an intervention will produce vertical shift of
the hazard function when plotted on log-linear axis populations, just as a change in the Gompertz
a or the Weibull β parameter does. (Fig. 3 a-b). PH models are formally defined by the relation
h1(t) = λh0(t), where h1(t) is the hazard function of a population exposed to some intervention
with h0(t) as the control group. Accelerated failure time models, in contrast to PH models, assume
that interventions produce a temporal rescaling of aging, stretching or compressing survival curves
such that S1(t) = S0(λt) (Fig. 3 c-d). AFT models offer an intuitive physical interpretation, that
interventions extend lifespan by decreasing the rate of the underlying physiological or cell biologic
processes that determine the timing of death. This is equivalent to a change in the Gompertz b or
Weibull β parameters.
Semi-parametric models are widely used in clinical research and therefore a deep literature exists
exploring their behavior in diverse contexts [24, 25]. Multivariate methods such as Cox regression
and Buckley-James regression allow multiple influences of lifespan to be considered simultaneously,
for example where environmental factors differ between experimental replicates [26] or when multiple
interventions are applied simultaneously. PH and AFT models often provide very good approximations
of empiric data in a variety of organisms, including yeast [27], flies [5], nematodes [22, 28], and mice
[29, 30] A variety of approaches exist to identify and compensate for situations where assumptions are
not met, including segmenting time or allowing continuously time-varying hazard ratios[31]. Additive
hazards (AH) models, assuming h1(t) = ∆h+ h0(t) have also been suggested [32].
AFT models, unlike PH models, produce residual distributions that take the same time units as
the death time provided. This allows residuals to subsequently be used as a time-standardized lifespan
4
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Figure 2: Parametric models of lifespan data. Various simple functions have been proposed to approximate
empiric lifespan data, shown as models of survival functions (left) and (right) hazard functions. Median lifespan is
marked as a single point on each corresponding curve. Geometric regularities in the influence of various parameters
are marked with gray arrows. a-b. The Gompertz distribution is commonly employed with the parameter a that
determines the risk of death in animals of zero age and b that determines the rate of increase in risk over time. c-d.
The alternate parameterization of the Gompertz model removes the implicit and often missed time-scale dependence
of the a parameter, allowing changes in initial mortality and changes in doubling time to be isolated, and allowing
the Gompertz function to model both changes in proportional hazards and changes in timescale. e-f. The Weibull
distribution models hazard functions that increase as a polynomial of time (in contrast to the exponential increase
assumed in by the Gompertz model). Weibull hazard functions therefore form straight lines when plotted on log-log
axes, rather than log-linear axes. g-h. Inverse Gaussian distributions exhibit inherently decelerating hazard functions,
and provide a link between lifespan data to the theory of Weiner Processes and Brownian motion.
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Figure 3: Semi-parametric models of
lifespan data. Semi-parametric models
describe differences between populations in a
way that does not depend on any particu-
lar parametric form of the survival curve of
hazard function. a-b. Proportional hazards
functions assume that two populations’ haz-
ard functions are offset by a constant ratio.
c-d. Accelerated Failure time models assume
that two populations’ survival curves are re-
lated by a temporal scaling, corresponding
to simultaneous shift of the hazard functions,
up and to the right such that h1(t) = λh0(λt)
e-f. Accelerated Failure time models are eas-
ily modified to model populations whose sur-
vival distributions are shifted (rather than
scaled) in respect to time. g-h. The exis-
tence of heterogeneity within a population in
respect to the risk of death produces a decel-
eration, or leveling-off of the hazard function
and a corresponding long-tail of the survival
function.
distribution for qualitative comparisons between different populations [28] and a convenient means for
handling confounding effects of environmental factors [33]. In cases where interventions do not slow
the aging process, but rather delay it by a fixed interval to produce a rigid shift (rather than a scaling)
of the survival curve, interventions can be modeled using similar methods assuming S1(t) = S0(t−∆τ )
(Fig. 3 e-f).
5. Accounting for heterogeneity within groups with frailty models
Basic parametric forms like Gompertz and Weibull are often employed with the implicit assumption
that all individuals in a population age according to the same parameters. This assumption is rarely
justified by experimental data, as even within isogenic populations of laboratory animals housed in
controlled laboratory conditions, subpopulations are observed to age in distinctive ways [34, 35, 36,
37, 38] ,[39]. Heterogeneity is also be produced when individuals respond unevenly to an intervention,
as is commonly observed[40], [41],[42].
The effect of the heterogeneity on the hazard and survival functions can be accurately modeled
even when it cannot be explicitly measured. This is accomplished by assuming the effect of the
unmeasured heterogeneity takes a simple parametric form as it varies between individuals. The
effect is then incorporated in a parametric or semi-parametric model and referred to as a “frailty” or
“random effect” term. A two-parameter Gompertz model, for example, can be modified to account for
heterogeneity in respect to its a parameter by adding a single additional parameter, σ, to represent
the variance of an gamma-distributed Z random variable, such that the hazard function becomes
h(t) = Z(σ)a exp(t/b)[43]. In this way, parametric and semi-parametric models can be modified to
account for unmeasured heterogeneity by adding a single additional parameter.
Heterogeneity of this kind produces a clear effect on hazard functions–a progressive deceleration
of hazard functions relative to the basic underlying parametric form [44], leading in some cases to a
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plateauing (flattening) of the hazard functions at advanced ages (Fig. 3 g-h). This deceleration arises
as a consequence of high-frailty, high-risk subpopulations dying earlier than low-frailty and low-risk
sub-populations. As the high-risk individuals die off, the remaining population increasingly consists of
relatively low-risk individuals. This change in the populations’ composition counteracts the increasing
risk of each individual, producing a quasi-stationary state in which the hazard rate appears flat [45].
Decelerating hazard functions are observed in most model-organism lifespan data. In some cases the
effects appear subtle, but in many cases late-life deceleration is a dominant feature of empiric hazard
functions, limiting the practical application of simple two parameter Gompertz or Weibull models
[44, 46, 47], [28]. Frailty-associated heterogeneity also confounds efforts to experimentally identify the
true parametric form of empiric data sets. Simple parametric models are most easily distinguished by
their behavior at late ages, at the tail of the parametric probability distribution. Heterogeneity masks
the underlying form of these tails, undermining biological interpretations that depend on empiric
justification of specific parametric forms [28] [48].
6. Accounting for multiple causes of death with competing risk models
Competing risks models explore the idea that though an organism can die only once, it remains at
risk of dying from multiple possible causes up until the moment that one particular cause kills it. These
models are most intuitively applied in populations in which individuals are suffering simultaneously
from several potentially fatal diseases–for example cancer patients with cardiovascular conditions [49].
Competing risk models explore quantitative relationships between causes of death, and provide a
framework in which to disentangle the effects of interventions that may not act homogeneously across
all mechanisms driving aging. For example, competing risk Cox regression and AFT regression models
can evaluate the simultaneous influence of multiple interventions on multiple causes of death[50].
Two classes of competing risks differ in their interpretation. One interpretation assumes that
all individuals share the same risk for each cause of death, and therefore describes the qualitatively
different outcomes produced by physiological changes experienced in the same way by all individuals.
Another interpretation assumes risks differ across sub-populations, with the extreme case being that
certain individuals have their cause of death pre-determined early in life. This latter assumption often
called “Mixture models” (Fig 4c-d), is of particular contemporary interest given the many types of
distinct subpopulations now being identified within isogenic populations [51]••[52, 53, 54].
Competing risk models involve data where each death time Ti is paired with a label Ci describing
the cause of death. This allows an intuitive decomposition of the all-cause hazard into the sum of
several cause-specific hazard functions,
h(t) =
∑
i hi(t) =
∑
i limP (t ≤ T + ∆t|T > t,C = Ci) as ∆t→ 0 [25], shown in Figures 1 and 4a-b.
Competing risk models were originally developed as an analytic tool for interpreting lifespan data.
However, the assumptions required to accomplish this task provide a useful starting point for exper-
imental researchers attempting to understand the physiological basis of aging. Are different causes
of death influenced equally by interventions in aging? Can genetically defined aging pathways be
contextualized in respect to their mutual dependence or independence in influencing different causes
of death? These questions can be rendered empirically testable by rephrasing them as testable quanti-
tative predictions of competing risk models. Recent work [28] [51],[55],[56] demonstrates the promise
of competing risk models to describe aging phenomena working at longer timescales, where differ-
ent physiological changes throughout life interact to determine the timing of death and the shape of
hazard functions and survival curves.
7. Describing multi-stage aging processes
The physiological changes driving aging may vary over the course of an individual’s lifespan. For
example, recent work has identified two phases of aging distinguished according to changes in move-
ment and behavior, transitions in gut permeability [57], changes in rate of apparent morphologic
7
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Figure 4: Modeling different types of heterogeneity. Several techniques exist to describe heterogeneity between
individuals within a population and over time during the aging process. a-b. Competing risk models describe the effect
that multiple causes of death have on a population’s hazard function. Here, three statistically-independent causes of
death exhibit different temporal dynamics. One cause (blue) shows a constant risk over time, another cause (green)
increases slowly with age and a third (red) increases rapidly later in life. The cause-specific hazard functions of each
cause sum to produce the all-cause hazar function and survival curve (black). c-d. In come cases, the cause of death of
an individual may be predetermined early in life, producing distinct subpopulations dying from distinct causes of death.
Here, thirty percent of individuals die early according to one cause of death (red) and the remainder die according
to a second cause (blue). In this case, the hazard functions do not strictly add. e-f. Survival and hazard functions
can be modeled with a “change-point” that separates distinct phases of aging. Though geometrically compelling, the
biological interpretation of segmented hazards is often problematic, as the break-point time must be uncorrelated with
each individual’s death time.
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changes[39], transcriptomic changes, [58, 59] ,[60], protein aggregation [61, 62], and differences in sus-
ceptibility to early-life [51] or late-life [63] bacterial infection. The best quantitative approach to model
these phases remains an open question and active area of research. In some cases, the physiological
distinctions between some phases may not correspond to distinct phases of the hazard function, in
which case no substantial changes are needed in survival analysis. In other cases, individuals in each
state may exhibit distinctive risk of death, and a class of multi-state models often called ”illness-death“
models will be applicable [64].
8. Biphasic and segmented hazard functions
A class of models have been proposed that separate aging into distinct phases relative to some
landmark, or ”change-point” specified in chronological time [65, 66, 67, 68]. (Fig 4.e-f). The biological
interpretation of these models is often problematic. For the hazard function to exhibit distinct phases,
the change-point between them must be determined either by some internal physiological process or by
some external factor–e.g. a shift in environment or diet. In the latter case, it is the environment that is
biphasic, not aging itself. The former case involves an apparent contraction, in that individuals variable
in their lifespan must nevertheless synchronously switch between phases. This would require that the
physiologic processes specifying the change-point in all individuals be at most weakly correlated with
the physiologic processes determining the timing of death of each individual. A more physiologically
plausible interpretation would seem to be that biphasic hazard functions arise not from a biphasic
aging process but instead from the distinct contributions of unidentified subpopulations, as described
by competing risks and mixture models.
Biphasic hazard models in many cases may simply represent an over-fitting or mis-fitting of empiric
data. For example, an apparently biphasic Gompertzian hazard function may be better explained by
a single-phase inverse Gaussian distribution or a single-phase Gompertzian distribution with an extra
parameter correcting for the effects of frailty.
9. Summary
Aging research is undergoing a period of rapid discovery and characterization of genetic, pharma-
ceutical, and dietary interventions in aging. Several of these therapies are being explored for transla-
tional potential, and lifespan data from human clinical trials may soon be available in which patients’
survival is altered by molecular perturbation of basic aging processes. This growing abundance of
lifespan data demands the thoughtful application of statistical methods.
For new projects, familiar analytic techniques should be re-evaluated. In particular, experimen-
talists should recognize that the Gompertz hazard parameterization became standard decades ago,
long before the high-resolution data needed to validate it became available. Experimentalists should,
as an alternative, consider frailty-corrected Gompertz distributions or semi-parametric methods like
AFT or PH regression. Where parametric analyses are justified, best-practice maximum likelihood
fitting methods should be employed. Finally, competing risks and mixture models should seriously
considered in situations where multiple aging processes may influence one or more outcomes in ag-
ing. Employing this broad tool set of analytic approaches, experimentalists can move beyond humble
significance testing to instead use lifespan data as a versatile means for studying the physiological
dynamics of aging.
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